Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

98
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
98
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

75.9K
Overview
75.9K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

104
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
104
Tissue Transplantation01:24

Tissue Transplantation

606
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
606
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

82
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
82

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Confronting complexities of uterus transplantation: Balancing Innovation, Risk and Access.

Fertility and sterility·2026
Same author

From burden to benefit: overcoming barriers to immunization in adults, with a focus on respiratory syncytial virus.

Expert review of vaccines·2026
Same author

Optimizing Matching in Liver Transplantation: Both, Donor and Recipient age Matter.

Transplantation·2026
Same author

Deceased Organ Donation and Transplantation in LIMC: A Meeting Report.

Transplantation·2026
Same author

Second report of registry of the International Society of Uterus Transplantation (ISUTx): international activities 2000-2024.

Human reproduction (Oxford, England)·2026
Same author

Organ Donation and Transplantation Worldwide: The Global Observatory on Donation and Transplantation 2024 Report.

Transplantation·2026

Related Experiment Video

Updated: Oct 18, 2025

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.3K

Immunosuppression after uterus transplantation.

Friederike Martin1, Stefan G Tullius2

  • 1Department of General, Visceral and Transplant Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Current Opinion in Organ Transplantation
|September 28, 2021
PubMed
Summary

Uterus transplantation (UTx) offers a path to biological childbirth for women with uterine factor infertility. Careful management of immunosuppression is crucial for maternal and infant health, drawing from solid organ transplantation experience.

More Related Videos

Murine Full-thickness Skin Transplantation
07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

20.6K
Surgical Approach, Challenges, and Resolutions for Uterus Transplantation in Rats
06:22

Surgical Approach, Challenges, and Resolutions for Uterus Transplantation in Rats

Published on: April 14, 2023

1.4K

Related Experiment Videos

Last Updated: Oct 18, 2025

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.3K
Murine Full-thickness Skin Transplantation
07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

20.6K
Surgical Approach, Challenges, and Resolutions for Uterus Transplantation in Rats
06:22

Surgical Approach, Challenges, and Resolutions for Uterus Transplantation in Rats

Published on: April 14, 2023

1.4K

Area of Science:

  • Reproductive Medicine
  • Transplant Immunology
  • Women's Health

Background:

  • Clinical uterus transplantation (UTx) is an emerging therapy for absolute uterine factor infertility.
  • UTx enables women to carry and deliver a biological child.
  • Immunosuppression protocols are vital for successful UTx outcomes and require careful balancing for mother and child.

Purpose of the Study:

  • To review current practices and accumulated experience in immunosuppression for uterus transplantation.
  • To highlight the unique, temporary nature of UTx and its implications for immunosuppression.
  • To discuss the adaptation of solid organ transplantation (SOT) immunosuppression strategies for UTx.

Main Methods:

  • Review of clinical uterus transplantation trials and accumulated immunosuppression data.
  • Analysis of immunosuppression strategies based on experience from solid organ transplantation.
  • Evaluation of treatment for acute T- and B-cell mediated rejections in UTx.

Main Results:

  • Accumulated clinical experience from UTx trials worldwide provides data on immunosuppression.
  • Immunosuppression has been successfully used for maintenance therapy and acute rejection treatment.
  • Current immunosuppression practices largely rely on established protocols from SOT.

Conclusions:

  • Immunosuppression in UTx is effective for managing rejection and enabling successful pregnancies.
  • Further understanding of UTx biology is needed to optimize immunosuppression strategies.
  • Refined approaches to immunosuppression will be key to advancing UTx procedures.